Prescription Drug Abuse | Behavioral Healthcare Executive Skip to content Skip to navigation

Prescription Drug Abuse

While talk about opioids continues in D.C., addiction treatment is in peril in states

March 5, 2018  |  Kaiser Health News

Opioids were on the White House agenda Thursday, but states say they are struggling to meet the need for treatment.

The White House opioid summit provides optimism

March 2, 2018  |  Ron Manderscheid, PhD, Exec Dir, NACBHDD and NARMH

On Thursday, I had the opportunity to participate in the White House Opioid Summit held in the East Room. This event represented the very first time that the administration has described its strategy for addressing the opioid tragedy.

Urgent actions needed on the opioid quandary

February 22, 2018  |  Ron Manderscheid, PhD, Exec Dir, NACBHDD and NARMH

We must come to grips with the lethal opioid epidemic, not just by bringing good intentions, but through positive actions that produce life-saving results. We must be open to whatever steps actually work.

MHA report offers glimpse of state trends

February 15, 2018  |  Rachael Zimlich, RN

The MHA report notes that 18% of adults nationally have a mental health condition, and about half of them have a concurrent substance use disorder. Half of those with mental health disorders go without treatment.

The least you need to know about ARCOS

February 14, 2018  |  Julie Miller, Editor in Chief

The DEA has launched an addition to its ARCOS tool. Now, drug manufacturers and distributors will be able to view more data in order to look for potential diversion of controlled substances.

Opioid crisis now $1 trillion problem

February 13, 2018  |  Tom Valentino

The opioid epidemic in the United States has cost $1 trillion since 2001 and is on pace to cost another $500 billion by 2020, according to a study released Tuesday by Altarum.

Pennsylvania needs more than public health emergency

January 16, 2018  |  Julie Miller, Editor in Chief

The treatment community says the governor's emergency declaration is a positive step but doesn't do enough to address long-term recovery and quality of care concerns.

County pushes toward elusive goal of treatment on demand

January 2, 2018  |  Rachael Zimlich, RN

King County, Wash., is offering addiction and mental health providers financial incentives for building systems to offer rapid access to care. The target is zero to one days, and the goal is to have 85% of patients covered in that range.

DEA operation flags 26 potentially rogue pharmacies

December 6, 2017  |  Tom Valentino, Senior Editor

An operation conducted by the DEA’s Los Angeles field division has identified 26 pharmacies in southern California, Hawaii and Nevada that are suspected of violating the Controlled Substances Act.

DEA creates Kentucky field division

November 29, 2017  |  Julie Miller, Editor in Chief

On Wednesday, the Drug Enforcement Administration (DEA) announced the establishment of a new DEA Field Division in Louisville, Ky.

Doctors make big money testing urine for drugs, then ignore abnormal results

November 29, 2017  |  Kaiser Health News

In nearly a dozen recent criminal cases, prosecutors have cited evidence that doctors supplied opiates to patients with repeated abnormal urine test results.

Cost analysis backs immediate access to agonist drugs for opioid dependence

November 29, 2017  |  Gary A. Enos, Contributing Editor

A cost-effectiveness analysis using California data makes a strong case for significant public investment in methadone and buprenorphine treatment.


Subscribe to Prescription Drug Abuse